Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Tesla Inc (TSLA) said on Monday that it would begin to export Model 3 sedans produced in China to at least ten European countries, among which Germany, France, Switzerland and Italy, later in October.

Tesla shares closed lower for a third consecutive trading session on NASDAQ on Monday. The stock went down 2.01% ($8.84) to $430.83, after touching an intraday low at $428.93, or a price level not seen since October 9th ($426.46).

Shares of Tesla Inc have risen 414.94% so far in 2020 compared with a 33.22% gain for the benchmark index, Nasdaq 100 (NDX).

In 2019, Tesla Inc’s stock went up 25.70%, thus, it underperformed the Nasdaq 100, which registered a 37.96% gain.

Tesla aims to achieve a production rate of 150,000 vehicles this year at its facility in Shanghai.

“Support from Chinese government towards the industry, innovative local companies and customers embracing new technologies make China the best market for smart electric vehicles,” the US electric car maker said in a statement, cited by Reuters.

The company also said it intended to expand vehicle production, charging as well as sales network in China, the largest auto market globally.

Analyst stock price forecast and recommendation

According to CNN Money, the 32 analysts, offering 12-month forecasts regarding Tesla Inc’s stock price, have a median target of $346.50, with a high estimate of $800.00 and a low estimate of $40.00. The median estimate represents a 19.57% downside compared to the closing price of $430.83 on October 19th.

The same media also reported that at least 16 out of 37 surveyed investment analysts had rated Tesla Inc’s stock as “Hold”, while 8 – as “Sell”. On the other hand, 10 analysts had recommended buying the stock.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Dollar Strength Lifts USD/CHF as Data Looms AheadDollar Strength Lifts USD/CHF as Data Looms Ahead Key Moments USD/CHF trades near 0.8090 in Asian hours as the pair rebounds from prior-day losses. Markets expect the KOF Swiss Leading Indicator to edge up to 98.2 in May from 98.0. Futures pricing implies nearly a 60% […]
  • China Announces 125% Tariff on US Goods, Nikkei 225 Slides Almost 3%China Announces 125% Tariff on US Goods, Nikkei 225 Slides Almost 3% Key momentsUS exports to China have been hit with a higher tariff of 125%. Nikkei 225 shed over 1,000 basis points on Friday, while the ASX 200 fell 0.82%. Korean stocks also dropped by 0.50%. The Hang Seng and SSE indices bucked this […]
  • Commodities trading outlook: crude oil and natural gas futuresCommodities trading outlook: crude oil and natural gas futures WTI and Brent futures were slightly lower during afternoon trade in Europe today. The US oil report pressured crude contracts yesterday, while Libya plans to gradually expand output. Meanwhile, natural gas futures slid as the US posted weekly […]
  • Grain futures mixed as U.S. harvest accelerates, unfavorable weather outlookGrain futures mixed as U.S. harvest accelerates, unfavorable weather outlook Grain futures were mixed on Tuesday after the USDA reported yesterday that field work in the U.S. picked up last week while corn and wheat condition remained relatively the same. Outlook for unfavorable weather in the U.S., South America and […]
  • Forex Market: USD/CAD daily trading forecastForex Market: USD/CAD daily trading forecast Yesterday’s trade saw USD/CAD within the range of 1.3287-1.3418. The pair closed at 1.3301, down 0.14% on a daily basis. It has been the first drop in the past six trading days. The daily high has been the highest level since June 30th 2004, […]
  • Lilly’s Foundayo Wins Key EMA Backing in EU Obesity RaceLilly’s Foundayo Wins Key EMA Backing in EU Obesity Race Key Moments The European Medicines Agency’s committee recommended Eli Lilly’s Foundayo for weight management and type 2 diabetes in adults. Foundayo generated $98 million in second-quarter sales after launches in the US in […]